1. Home
  2. SES vs TTRX Comparison

SES vs TTRX Comparison

Compare SES & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SES AI Corporation

SES

SES AI Corporation

N/A

Current Price

$0.77

Market Cap

256.7M

ML Signal

N/A

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

N/A

Current Price

$10.09

Market Cap

298.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SES
TTRX
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
256.7M
298.8M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
SES
TTRX
Price
$0.77
$10.09
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $25.00
AVG Volume (30 Days)
★ 25.9M
83.7K
Earning Date
11-12-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 29.03
N/A
EPS
★ N/A
N/A
Revenue
★ $21,000,000.00
N/A
Revenue This Year
$55.89
N/A
Revenue Next Year
$131.57
$900.00
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 929.41
N/A
52 Week Low
$0.49
$2.57
52 Week High
$2.62
$16.45

Technical Indicators

Market Signals
Indicator
SES
TTRX
Relative Strength Index (RSI) 52.90 42.31
Support Level $0.51 $10.05
Resistance Level $0.99 $10.72
Average True Range (ATR) 0.11 0.78
MACD -0.00 -0.02
Stochastic Oscillator 48.00 29.98

Price Performance

Historical Comparison
SES
TTRX

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of rechargeable battery technologies and battery materials for Energy Storage Systems (ESS), Urban Air Mobility (UAM), drones, robotics, electric vehicles (EVs), and other applications. For Enery Storage Systems, the company supplies hardware and software solutions with battery health and safety management software powered by its AI-based platform, Molecular Universe. Additionally, it offers battery materials and high-energy and power-density Li-Metal and Li-ion cells, which can be used for drones, UAM, robotics, and EV applications. The company also offers access to Molecular Universe as a software product. Currently, it generates maximum revenue from the development of Li-ion and Li-Metal battery materials as per the client's specifications.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: